sellWeak
Bryan Ball sold $6,070 of WHWK
See remarks at Whitehawk Therapeutics, Inc.. 1,834 shares at an average of $3.31, traded Mar 2, 2026, filed Mar 10, 2026.
Warning score
0Value
$6,070
1,834 shares
Holdings after
206,019
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$6k at market
- 0Share of holdings soldSold 0.9% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001766522-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 1, 2026 | MOption exercise Common Stock | +5,000 | - | - | 207,853 | Mar 10, 2026 |
| Mar 2, 2026 | SOpen-market sale Common Stock | -1,834 | $3.31 | $6,070 | 206,019 | Mar 10, 2026 |
| Mar 1, 2026 | MOption exercise Restricted Stock Unitsderivative | -5,000 | $0.00 | $0 | 10,000 | Mar 10, 2026 |
Related signals
Other insiders at Whitehawk Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | Whitehawk Therapeutics, Inc. | Bryan Ball See remarks | $5,045 2,147 shares | -2% | |
| 30Weak | Whitehawk Therapeutics, Inc. | David James Lennon CHIEF EXECUTIVE OFFICER | $13k 5,690 shares | -15% | |
| 27Weak | Whitehawk Therapeutics, Inc. | Scott M. Giacobello CHIEF FINANCIAL OFFICER | $6,594 2,806 shares | -10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.